Gregor Obernosterer

Sequencing Solutions, Roche Diagnostics | Portfolio Management, RoX Health

Berlin, Berlin, Germany

About

I thrive where science, business, and human need meet. As a strategic shaper with a bias for action, I turn complex ideas into solutions that create real-world impact. At Roche Diagnostics Germany, I lead key genomics accounts with full commercial responsibility, driving adoption of advanced sequencing technologies — from NGS and the AXELIOS sequencer. My focus: turning scientific innovation into market success. In parallel, I lead portfolio management at RoX Health, Roche’s digital health venture builder. There, I help shape and scale ventures that push healthcare forward with speed, clarity, and commercial rigor. Spanning both genomics and digital health, I bridge innovation and execution — building what’s next, and making it work in the real world.

Experience

  • Head of Portfolio Management - Driving RoX as Roche’s Early Innovation Engine at RoX Health

  • Strategic Partnerships Lead Sequencing Solutions at Roche

  • Sr. Innovation Lead at RoX Health

  • Director Business Development at RoX Health

  • Oncology Innovation Manager at Roche

  • Sr. Account Manager Sequencing Solutions at Roche

  • Postdoctoral Fellow at The Netherlands Cancer Institute

  • Postdoctoral Fellow at Whitehead Institute

  • CSSS at Santa Fe Institute

  • Postdoctoral Fellow at The Netherlands Cancer Institute

  • Postdoctoral Fellow at Whitehead Institute

  • CSSS at Santa Fe Institute